Vaccine biotechs get stop-work orders for their next-gen Covid worknews2025-04-22T19:07:46+00:00April 22nd, 2025|Endpoints News|
AstraZeneca rejoins PhRMA, two years after leaving lobby groupnews2025-04-22T18:57:12+00:00April 22nd, 2025|Endpoints News|
Regeneron to boost its US manufacturing through a $3B Fujifilm dealnews2025-04-22T17:11:26+00:00April 22nd, 2025|Endpoints News|
Drugmakers stockpile inventory in the US, seeking to get ahead of Trump tariffsnews2025-04-22T14:00:06+00:00April 22nd, 2025|Endpoints News|
Roche promises $50B investment in the US as pharma tariffs inch closernews2025-04-22T10:38:39+00:00April 22nd, 2025|Endpoints News|
AstraZeneca, Daiichi eye first-line breast cancer market after Enhertu’s early Phase 3 winnews2025-04-22T10:16:36+00:00April 22nd, 2025|Endpoints News|
Alvogen unit appeals court loss in bid to market Xifaxan genericnews2025-04-21T17:04:09+00:00April 21st, 2025|Endpoints News|
GSK’s myeloma drug Blenrep wins authorization from UK regulatorsnews2025-04-17T17:15:49+00:00April 17th, 2025|Endpoints News|
CMS would absorb 340B drug discount program under leaked HHS proposalnews2025-04-17T15:50:52+00:00April 17th, 2025|Endpoints News|
US drugs rely heavily on ingredients made overseas — reportnews2025-04-17T15:14:23+00:00April 17th, 2025|Endpoints News|
